Supira Medical key facts
as of Oct 2026- Developer of a percutaneous ventricular assist device designed to treat high-risk coronary interventions and cardiogenic shock.
- Supira Medical is valued at approximately $445.0M as of Oct 2026, set at its later-stage round, Mar 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $241.0M across 6 recorded rounds; the latest was Later Stage VC ($120.0M) in Mar 2025.
- Notable investors include Novo Holdings, Qatar Investment Authority, Cormorant Asset Management, TCP Health Ventures, 415 Capital — 10 tracked in total.
- Supira Medical has filed 6 Form Ds with the SEC since 2017, most recently Apr 2025 ($120.0M sold to 20 investors).
- Status: Privately Held (backing).
Valued at $445.0M at its later-stage round, Mar 2025. Nothing has traded since.
- ·Watch Supira Medical: the Monday email on marks, rounds and moves
Supira Medical funding rounds
6 roundsSupira Medical valuation
Supira Medical was valued at $445 million at its later-stage round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Supira Medical raised?
Supira Medical has raised $241 million across 6 recorded rounds since 2017. The largest was a $35.1 million early-stage round in Feb 2020; the most recent was a $120 million later-stage round in Mar 2025.
Supira Medical has filed 6 Form Ds with the SEC since 2017, most recently in Apr 2025 ($120 million sold to 20 investors).
Supira Medical investors
10 investors are on record for Supira Medical, including Novo Holdings, Qatar Investment Authority, Cormorant Asset Management and TCP Health Ventures. The later-stage round in Mar 2025 drew 20 investors.
About Supira Medical
Developer of a percutaneous ventricular assist device designed to treat high-risk coronary interventions and cardiogenic shock. The company's device provides temporary mechanical support for severe coronary artery disease or comorbidities to treat patients suffering from cardiogenic shock, enabling patients to recover from heart problems.
- Sector
- Healthcare
- HQ
- Los Gatos, CA, United States
- Founded
- 2012
- Employees
- 125
- Website
- supiramedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.